300+
significant mutations
Micro Solutions / Life Science
NGS panel of solid tumors: more than 300 significant mutations for about 35 types of cancer
NGS panel of solid tumors: more than 300 significant mutations for about 35 types of cancer
Seoul Asan Medical Center in collaboration with Dana-Farber Cancer Institute
ONCOaccuPanel is an NGS panel for solid tumors, covering more than 300 clinically relevant mutations for nearly 35 types of cancer.
The panel tests more than 300 clinically relevant mutations, which are specific to about 35 solid tumor types — lung, colon, stomach, breast, and others. The reagents are delivered as a ready-made liquid kit for sequencing tissue samples of tumors. The panel was developed jointly by Seoul Asan Medical Center and Dana-Farber Cancer. Institute.
ONCOaccuPanel is registered with CE-IVD certification.
significant mutations
solid-type
registration
| Coverage of mutations | More than 300 significant mutations |
|---|---|
| Tumor types | about 35 types of solid tumors |
| Type of sample | solid-tumour |
| Reagent | liquid |
|---|
| Status | CE-IVD |
|---|